Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gunderson Dettmer is an international law firm founded in Silicon Valley in 1995 that specializes exclusively in business law for emerging growth companies—including those in the technology and life science sectors—and their investors. While it does not itself develop drugs or medical products nor conduct clinical research or manufacturing activities typical of biotech/pharma/CROs/CMOs/etc., it plays an influential role advising hundreds of high-growth startups from inception to exit on financings/IPOs/M&A/licensing/commercial agreements/intellectual property matters. Its client base includes many prominent biotechs/pharmas at all stages of development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gunderson Dettmer.